The Relationship Between Metacognitive Beliefs and Salivary Cortisol, BDNF, and NDNF Levels: A Cross‐Sectional Study
Brain and Behavior · 2025-12 · 15 (12)
DOI: 10.1002/brb3.71063 ↗Kurz gefasst
Fachartikel in der Zeitschrift Brain and Behavior, online erschienen am 10.12.2025. Verfasst von Süheyb Okur und 2 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Theology, Programme in Philosophy And Religious Studies, Department of Religious Psychology, Bayburt University, Bayburt, Türkiye. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Hydrocortisone, Metacognition. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
The main objective of this study is to non‐invasively investigate the relationship between metacognitive beliefs and cortisol, the primary stress output of the hypothalamic‐pituitary‐adrenal (HPA) axis, as well as neurotrophic factors associated with neuroplasticity brain‐derived neurotrophic factor and neuron‐derived neurotrophic factor (BDNF and NDNF). Within this framework, the hypotheses that negative metacognitions would be associated with increased cortisol and decreased BDNF levels, and that cortisol might play a mediating role in this relationship, were tested.
Method
The study was designed in a cross‐sectional model with 60 university students. Participants' metacognitive beliefs were measured using the Metacognitions Questionnaire‐30 (MCQ‐30). Salivary cortisol, BDNF, and NDNF levels were analyzed using the ELISA method. Pearson correlation and hierarchical multiple regression analyses were used for data analysis. Finding The results showed a significant positive relationship between the total metacognition score and cortisol ( r = 0.589, p < 0.01) and a strong negative relationship between cortisol and BDNF ( r = −0.662, p < 0.01). Hierarchical regression analysis supported a partial mediation model, indicating that dysfunctional metacognitive beliefs have both a significant direct negative association with BDNF and an indirect association mediated by cortisol. In the final model, both metacognition ( β = –0.298, p < 0.05) and cortisol ( β = –0.281, p < 0.05) were significant factors associated with lower BDNF levels. NDNF showed a positive relationship with BDNF ( r = 0.571) but not with other variables.
Conclusion
These findings point to a psychobiological model where dysfunctional metacognitive beliefs are linked to suppressed neuroprotective mechanisms like BDNF, both directly and indirectly through HPA axis activation. The results shed light on the potential neurobiological mechanisms underlying the effectiveness of metacognitive therapies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Theology, Programme in Philosophy And Religious Studies, Department of Religious Psychology, Bayburt University, Bayburt, Türkiye.
- Faculty of Health Sciences, Department of Physiotherapy and Rehabilitation, Bayburt University, Bayburt, Türkiye.
- Faculty of Theology, Programme in Philosophy and Religious Sciences, Department of Philosophy of Religion, Bayburt University, Bayburt, Türkiye.
ORCID-Profile: Süheyb Okur, Bülent Bayraktar, Fatma Tosun Köse
Zitieren
APA
Okur, S., Bayraktar, B., & Tosun Köse, F. (2025). The Relationship Between Metacognitive Beliefs and Salivary Cortisol, BDNF, and NDNF Levels: A Cross‐Sectional Study. Brain and Behavior, 15(12). https://doi.org/10.1002/brb3.71063
Vancouver
Okur S, Bayraktar B, Tosun Köse F. The Relationship Between Metacognitive Beliefs and Salivary Cortisol, BDNF, and NDNF Levels: A Cross‐Sectional Study. Brain and Behavior. 2025;15(12). doi:10.1002/brb3.71063
BibTeX
@article{Okur2025,
author = {Okur, Süheyb and Bayraktar, Bülent and Tosun Köse, Fatma},
title = {The Relationship Between Metacognitive Beliefs and Salivary Cortisol, BDNF, and NDNF Levels: A Cross‐Sectional Study},
journal = {Brain and Behavior},
year = {2025},
volume = {15},
number = {12},
doi = {10.1002/brb3.71063}
}
EUVIMED